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• GAP43 and CASP3 are primarily present in neurons after stroke.
• Expression of Gap43 and Casp3 increased after onset of stroke.
• GAP43 and CASP3 colocalized after onset of stroke.
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a b s t r a c t
GAP43 is a protein involved in neurite outgrowth during development and axon regeneration reﬂecting
its presynaptic localization in developing neurons. Recently, it has been demonstrated that GAP43 is a
ligand of CASP3 involved in receptor endocytosis and is also localized post-synaptically. In this study, by
using a transgenic mouse strain carrying a bioluminescent reporter for GAP43 combined with an in vivo
bioluminescence assay for CASP3, we demonstrated that one day after brain ischemic lesion and, even
more pronounced, four days after stroke, expression of both CASP3 and Gap43 in neurons increased more
than 40 times. The in vivo approach of CASP3 and GAP43 colocalization imaging was further validated
and quantiﬁed by immunoﬂuorescence. Importantly, in 82% of GAP43 positive cells, colocalization with
CASP3 was present. These ﬁndings suggested that one and four days after stroke CASP3 expression, not
necessarily associated with neuronal death, increased and suggested that CASP3 and GAP43 might be
part of a common molecular pathway involved in early response to ischemic events occurring after onset
of stroke.
© 2015 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
GAP43 (growth-associated protein-43) is a protein associated
with neurite growth during development and regeneration of the
nervous system. It promotes accumulation of F-actin in neurites,
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contributing to the formation of the cytoskeleton [1,2]. Gap43
expression is highest during critical periods of neural systemdevel-
opment [3,4]. Perinatally it is expressed in all neurons, but its
expression diminishes with decrease of axonal arborization and
synaptogenesis and remains only in high-plasticity areas, such as
the hippocampus and the olfactory bulb in mice [5]. Recently it
has been shown that GAP43 in neurons is a substrate for CASP3
(caspase 3) and that mutation of Gap43 causes decreased endocy-
totosis of the -amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid (AMPA) receptor leading to impaired long term depression on
the level of postsynaptic membrane [6]. This suggested new roles
for both CASP3 and GAP43 in the nervous system.
http://dx.doi.org/10.1016/j.neulet.2015.04.042
0304-3940/© 2015 Elsevier Ireland Ltd. All rights reserved.
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After onset of stroke, one of the most prominent regenerative
events is axonal sprouting in the penumbra, which is accompanied
by high expression of GAP43 [7–10]. Since CASP3 is a protease,
not only involved in apoptosis but also in the ﬁne tuning of
formationof newsynaptic contacts [11], and sinceGAP43 is anewly
discovered postsynaptic substrate for CASP3 [6], we hypothesized
that GAP43 and CASP3 together might be part of a recently sug-
gestedGAP43/CASP3 commonmolecular pathway and that it could
be involved in tissue response after stroke.
To visualize levels of GAP43 after stroke, we used transgenic
mice bearing the luciferase (luc) and green ﬂuorescence pro-
tein (gfp) reporter genes under the control of the murine Gap43
promoter (C57Bl/6-Tg(Gap43-luc/gfp) 10Kri) [12]. By using the
luciferase substrate VivoGloTM Caspase 3/7 Substrate (Promega),
we were able to detect a subpopulation of CASP3 positive cells
among GAP43 cells.
Our results revealed that expression of both CASP3 and GAP43
after stroke signiﬁcantly increased (more than 40 times increase by
optical densitymeasurements andmore than200 times increase by
counting positive cells). Moreover, in 82% of GAP43 positive cells,
colocalizationwith CASP3was detected. This colocalization further
suggests that after stroke CASP3 activity in association with GAP43
could be non-apoptotic.
2. Materials and methods
2.1. Animals
A transgenic C57Bl/6-Tg(Gap43-luc/gfp) 10Kri mouse line was
generated by Gravel and co-workers and genotyped by polymerase
chain reaction (PCR) detection of the luciferase reporter gene as
previously described [12,13]. For in vivo imaging 4 animals were
used, while ex vivo experiments included 3 groups of animals:
baseline (N=4), 24h (N=5) and 4 days (N=5) with mortality of
5% accounting for 1 animal that reached an ethical endpoint before
the experimental time point (2 days) in 4 days group. Total number
of animals used was 19.
2.2. Transient middle cerebral artery occlusion (tMCAO)
In order to visualize neuronal responses to injury and repair,
we chose the tMCAO method. It is based on unilateral transient
focal cerebral ischemia by intraluminal ﬁlament occlusion of the
left middle cerebral artery for 1h followed by a reperfusion period
previously described [14]. It has been shown that thismethod gives
the highest level of reproducibility and it is the most often used
approach in research of brain ischemia/stroke.
2.3. In vivo bioluminescence imaging
As previously described the images were gathered using the
IVIS 200 Imaging System (PerkinElmer, Waltham, MA, USA) [13].
The validity of the Gap43 transgenic mice to mirror Gap43 expres-
sion by reporter genes was described previously by one of us
[12]. The luciferase substrate VivoGloTM Caspase 3/7 Substrate (Z-
DEVD-Aminoluciferin Sodium Salt, Promega, Madison, WI, USA)
was injected intraperitoneally 20min prior to the imaging session.
The mice were anesthetized with 2% isoﬂurane in 100% oxygen at a
ﬂow rate of 2 L/min, placed in the heated light-tight imaging cham-
ber, and maintained anesthetized by constant delivery of the 2%
isoﬂurane–oxygen mixture at 1 L/min through an IVIS anesthesia
manifold. To obtain baseline expressionmeasurements, all animals
(N=4) were imaged before and then ﬁrst and fourth day following
the injury.
The light output was quantiﬁed by determining the total num-
ber of photons emitted per second (p/s) using the Living Image
4.0 acquisition and imaging software (PerkinElmer, Waltham, MA,
USA). Region of interest measurements on the images were used to
convert surface radiance (p/s/cm2/sr) to source ﬂux or total ﬂux of
photons expressed in photons/seconds.
2.4. Tissue collection
Animals were anesthetized by an intraperitoneal injection of
2.5% Avertin (Sigma–Aldrich, St. Louis, Mo, USA) and then transcar-
dially perfused with 0.9% saline, followed by 4% paraformaldehyde
(PFA) at pH 7.4 dissolved in phosphate-buffered saline (PBS). Iso-
lated brains were postﬁxed overnight in 4% PFA, equilibrated in
PBS/30% sucrose for 48h, embedded into Tissue-Tek (O.C.T. com-
pound, Sakura, USA), frozen at −20 ◦C, cut into 30m thick coronal
section with a Cryostat (Leica, Wetzlar, Germany), and stored at
−20 ◦C.
2.5. Immunoﬂuorescence
Brain sections were blocked for 30min in PBS containing 10%
goat serum and 0.25% Triton X-100. Sections were then incubated
overnight at room temperature with 1:250 primary antibody rab-
bit polyclonal anti-cleaved CASP3 (Cell Signaling, Danvers, MA,
USA), 1:125, 1:250 primary antibody rabbit polyclonal anti-GFP
(Merck Millipore, Billerica, MA, USA) used for GAP43 visualization,
1:1000 primary antibody chicken polyclonal anti-GFAP (Abcam,
Cambridge, UK) and 1:250 primary antibody mouse monoclonal
anti-Neu-N (Merck Millipore, Billerica, MA, USA). Afterwards, sec-
tions were incubated for 2h at room temperature in corresponding
secondary Alexa-Flour antibody 1:500 (Invitrogen, Eugene, OR,
USA).Afterbothprimaryandsecondaryantibodyapplication, slides
were givenﬁve10-minwashes in PBSwith0.1%TritonX-100deter-
gent. Two additional washings of 1min each were done before
mounting the slides with Dako Fluorescence Mounting Medium
(Dako, Denmark). Beforemicroscopy, slideswere left to dry off over
night at room temperature.
2.6. Quantiﬁcation of the immunoﬂuorescent signal
For the quantiﬁcation of the immunoﬂuorescent signal (Cleaved
CASP3, GAP43) four ﬁelds of view per section (every sixth section,
all ischemic lesion area), ten sections per animal were acquired
on a ﬂuorescent microscope (Axiovert 200, Zeiss, Oberkochen,
Germany) from the perilesional ipsilateral and corresponding con-
tralateral cortex. Immunoreactivitywas quantiﬁedwith the ImageJ
software by measuring the integrated optical density (intensity of
ﬂuorescence per unit of surface area), and number of maxima. The
results were expressed in arbitrary units as previously described
[13]. For the quantiﬁcation of cells positive for either of markers,
thenumberof positive cells in aﬁeldof viewwas countedmanually.
2.7. Confocal imaging and reconstruction
The microscope used was IX81 Olympus microscope equipped
with a confocal scan unit FV500 with 3 laser lines: Ar–Kr (488nm),
He–Ne red (646nm) and He–Ne (532nm) and UV diode (Olympus,
Tokyo, Japan). Images were taken sequentially in Laser Scanning
Microscopy (LSM) modality, using a step size as close as possible to
pixel size for z-axis. Acquired multi-page TIF ﬁles were uploaded to
Imaris software (Bitplane AG, Zuerich, Switzerland), and processed
as described previously [15].
2.8. Statistical analysis
For in vivo imaging results the unpaired Student’s t-test was
used to compare the total photon emission in two different regions
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Fig. 1. Immunohistochemistry of GFP signal, which was driven by Gap43 promoter in our transgenic mice showing colocalization with neuronal marker NeuN. In contrast,
when compared with GFAP, a marker of astrocytes, no colocalization was observed in the ischemic penumbra. Size marker 20m.
of interest (ROI) in the same mouse at the same time point. As con-
ﬁrmed by F test, the variances were equivalent between the two
groups.
The data from quantiﬁcation of immunoﬂuorescent signal for
both IODandcell countswereaveragedandanalyzedby1wayanal-
ysis of variance of the 6 groups followed by Bonferonni’s multiple
comparison test.
Using data averaged per given animal, correlation tables were
assembled observing the R2 value of correlation coefﬁcient.
3. Results
3.1. GAP43 and CASP3 were primarily present in neurons after
ischemic lesion
To determine which cells contained GAP43 and CASP3, we
performed double immunohistochemistry for proteins markers
of the astrocytes and neurons on ischemic mouse brain tissue.
GAP43/NeuN double immunohistochemistry revealed that GAP43
was exclusively expressed in neurons. Based on GAP43/GFAP, no
presence of GAP43 in astrocytes was found (Fig. 1).
CASP3was also foundprimarily in neurons; a signalwas present
in astrocytes as well, to a lesser degree (Fig. 2).
3.2. Expression of Gap43 and Casp3 signiﬁcantly increased after
onset of ischemic lesion
To analyze how stroke inﬂuenced the expression of Gap43 and
Casp3, we induced it using the MCAO approach. We performed
immunohistochemical and bioluminescence analyses and quanti-
ﬁed expression by measuring optical density and cell counting.
Immunohistochemistry revealed that already one day after
ischemic lesion and, even more pronounced, four days after
ischemic lesion, expression of GAP43 and CASP3 signiﬁcantly
increased (Fig. 3) as detected by one-way ANOVA test (P<0.0001).
Optical density method revealed that expression of GAP43
increased 27 fold one day after ischemic lesion, while 4 days after
ischemic lesion, the increase was 47 fold. The cell count method
revealed that, one day after ischemic lesion, the number of GAP43
Fig. 2. CASP3 was predominantly present in NeuN positive cells, but also at lower level in GFAP positive cells 4 days after tMCAO. Arrows are pointing to regions of clearly
visible double immunohistochemistry positive signal. The ﬁgures correspond to penumbra, peri-infarct region of cortex. Size marker 10m.
D. Gorup et al. / Neuroscience Letters 597 (2015) 176–182 179
Fig. 3. Immunohistochemistry of GFP signal, which was driven by Gap43 promoter, and CASP3 at baseline, 1 and 4 days after stroke in ipsilateral cortex. The increase in both
GFP and CASP3 intensities after stroke is clearly visible. The ﬁgures correspond to penumbra, peri-infarct region of cortex. Size marker 20m.
Fig. 4. Statistically signiﬁcant increase for both GAP43 and CASP3 signal was found when both 1 day and 4 days after tMCAO were compared to their contralateral (healthy)
hemisphere brain baselines. This increase was found when both integrated optical density and cell count methods were applied. Moreover, when integrated optical density
was applied, a statistical signiﬁcant increase was found for both GAP43 and CASP3 when signals were compared between 1 and 4 days inside ischemia affected hemisphere.
There was no statistically signiﬁcant difference when cell count method compared GAP43 and CASP3 signal between 1 and 4 days inside ischemia affected hemisphere.
Average values are represented by columns heights and error bars represent standard error. Data collected correspond to penumbra, peri-infarct region of cortex.
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positive cells increased 206 fold and 4 days after ischemic lesion
the number of GAP43 positive cells increased 205 fold (Fig. 4). The
optical density method (IOD) revealed that expression of CASP3
increased 24 fold one day after ischemic lesion, while 4 days after
ischemic lesion, the increase was 42 fold. The cell count method
indicated that one day after ischemic lesion number of CASP3 posi-
tive cells increased 203 fold and 4 days after ischemic lesion the
number of CASP3 positive cells increased 205 fold (Fig. 4). The
increase of GAP43 signal after tMCAO correlated with CASP3 signal
intensity (R2 =0.79, Supplementary Fig. S1).
Previous work on this transgenic animal model showed
that there is a low basal level of endogenous GAP-43 protein
present in ﬁbrillary/punctate formations, and high-magniﬁcation
immunoﬂuorescence analysis of thedifferent brain regions showed
colocalization of endogenous protein and theGAP-43-driven trans-
gene GFP in the CA1 and CA3 pyramidal cells of the hippocampus
[12].
Since the signal is present in the brain structures affected by
MCAO, including the frontal and parietal cortex, striatum, and hip-
pocampus, depending on the lesion size,we focused onperilesional
cortex as a representative region of neuronal activation.
The number of GAP43 positive cells increased 1 and 4 days after
tMCAO compared to the baseline and to the contralateral hemi-
spheres of each timepoint. However, the number of GAP43positive
cells did not signiﬁcantly differ when comparing 1 and 4 days post-
ischemia.
Similar ﬁndingsweredetected for cleavedCASP3 showing adra-
matic increase the ﬁrst day after ischemic lesion compared to the
baseline and contralateral hemisphere levels. This increase per-
sisted even 4 days after the lesion.
When counted percentage of neurons positive for CASP3, their
number increased from less than 1% in healthy cortices to 33% and
42% of CASP3 positive neurons in peri-infarct cortices 1 and 4 days
after tMCAO, respectively (Fig. S4). In the same region percentage
of neurons positive for GAP43 was 1% in controls, which increased
to 26% and 25% 1 and 4 days after tMCAO, respectively (Fig. S4).
Regarding astrocyte marker GFAP, it colocalized with CASP3 in
4% of cells in healthy brain and 13% and 14% cells 1 day and 4 days
after tMCAO, respectively (Fig. S4). As mentioned above, there was
no expression of GAP43 in astrocytes, neither before nor after the
stroke.
3.3. GAP43 and CASP3 signiﬁcantly colocalized after onset of
ischemic lesion
To test the in vivo coexpression of GAP43 and CASP3 we
used in vivo bioluminescence imaging using VivoGloTM Caspase
3/7 substrate (Promega). Since Caspase7 is exclusively activated
following activation of CASP3, and since CASP3 ismuchmore abun-
dant protein and represents far the biggest portion of the signal
in this system, this substrate allowed us to measure expression
of luciferase driven by GAP43 promoter in CASP3 positive cells.
Fig. 5. Increase of GAP43/CASP3 colocalization signal using Vivo-Glo substrate for Caspase3/7 measured by bioluminescence (A and B), integrated optical density (C) and
cells count (D). (A and B) Bioluminescent in vivo imaging detecting GAP43/CASP3 colocalization was visible 4 days after stroke, as presented in columnar view. (C) Integrated
optical density method performed on slides revealed a signiﬁcant increase in GAP43/CASP3 colocalization between 1 and 4 days after onset of brain ischemia. (D) Cells count
method revealed a signiﬁcant GAP43/CASP3 colocalization signal for both 1 and 4 days after onset of brain ischemia. The ﬁgures correspond to penumbra, peri-infarct region
of cortex.
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Analysis of the bioluminescent signal revealed GAP43/CASP3 colo-
calization after one day and a signiﬁcantly higher signal 4 days
after MCAO (Fig. 5). In our hands, baseline values of the signals in
healthy GAP43 animals regularly correspond to signals in healthy
hemispheres of ischemia affected animals (also described in [12]).
Therefore, in this work we used contralateral hemispheres for
baseline values, thus following the recommendation of our ethical
board and sparing the animals unnecessary stress.
Using immunoﬂuorescence, IOD showed increased overlap sig-
nal although no difference in the number of cells exhibiting
GAP43/CASP3 colocalization was detected between days 1 and 4.
Colocalization signalwas also conﬁrmedusing confocalmicroscopy
and 3D reconstruction (Supplementary Figs. S2 and S3).
4. Discussion
Themain events occurring after onset of ischemic lesion include
activation of molecular pathways associated with inﬂammation
and tissue regeneration [16,17]. Adult cortex inmammals responds
to injury with axonal sprouting, with GAP43 being one of the
key players in the outgrowth of new axons [7–9,18]. Other genes
involved in this process are mostly linked to formation of neuro-
ﬁlaments, microtubules or myelin. In rodents affected by tMCAO,
GAP43 is present during the early phase in the focus of ischemic
lesion, followed by expression in penumbra [18]. This suggested
an early role for GAP43 in the rescue and regeneration of tissue. In
permanent MCAO, where tissue is more and irreversibly damaged,
there is no GAP43 in the lesion focus, but its expression is increased
in penumbra, reaching its maximum at day 7 [19]. Elucidation of
the role of GAP43 has evolved with the recent discoveries that
GAP43 is also present on the postsynaptic membrane and can be a
substrate for CASP3 [5,10]. Discovery of the postsynaptic location
of this protein shifted understanding of its role from mechanical
elongation of cell projections toward more complex tuning of the
intercellular networks needed for proper tissue regeneration. The
next important step towards elucidation of the role of GAP43 and
CASP3camewith recentﬁndingswhich reported thatCASP3canact
on 56 substrates in neurons, and apart from GAP43, it is involved in
pathways associatedwith the control of neuronal cytoskeletal com-
ponents and their regulators (e.g., actin, MAP2, GAP43, Dbn1, and
calmodulin) [6]. This added a new dimension to the understanding
of regeneration after ischemic lesion: cell death is tightly corre-
lated to elongation of newcell processes and linked toﬁne tuning of
newly formed intercellular connections. By integrating the recent
ﬁndings, we hypothesized that CASP3 and one of its major ligands,
GAP43, are involved in a common pathway in the early response
following stroke.
Our results show that both GAP43 and CASP3 increase rapidly
and dramatically after stroke and this increase occurred in a lin-
ear correlation. Since neuroinﬂammation is a very complex, partly
individual and not always easily repeatable process, it was impor-
tant to minimize variability as much as possible. Our noninvasive
in vivo bioluminescence tracking allowed repetitive assessment of
localization and quantiﬁcation of the cell signal on the same ani-
mals. The observed signal increase of both GAP43 and CAP3 using
bioluminescence was further analyzed in detail using histological
slides. Increase in the signal was quantiﬁed using both established
methods for quantiﬁcation of bioluminescence signal and of histo-
logical slides. The analysis revealed that the increase in the signal
intensity of both GAP43 and CASP3 after onset of stroke was not
due to an increase in the number of cells expressing those genes.
This leads to conclude that both GAP43 and CASP3 belong to genes
activated in the earliest stage after onset of stroke and that it is the
cells involved in the regenerative processes that trigger the expres-
sion of these two genes, which is in opposition to an apoptotic
process. A similar ﬁndingwas obtainedwith colocalization analysis
which showed that GAP43 exhibits relatively stronger expression
on the ﬁrst day after stroke as compared to CASP3, followed by an
increased expression of CASP3 after 4 days, butwithout an increase
in cell number, resulting in an increase of colocalization. Although
the observed events, here described for the ﬁrst time, are still not
completely understood, we can propose themodel inwhich GAP43
reacts as an early signal for axonogenesis, followed by an acceler-
ated increase of CASP3 not acting as a pro-apoptotic molecule, but
more as to control its substrate GAP43. Colocalization within the
same cells highly suggests their importance in ﬁne tuning of axonal
elongation and cytoskeletal reorganization, as major elements of
regeneration of the nervous system.
5. Conclusion
Here we have shown using bioluminescent imaging and
immunohistochemistry that expression of GAP43 and CASP3 fol-
lowing MCAO were linked to each other. Following their recently
described presence in both pre- and post-synaptic compartments
and the link with cytoskeletal proteins, here we propose that these
twoproteinsmay act in a coordinatedway in the regulation of brain
response and repair after stroke.
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